Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted CPT vs Standard CPT for Veterans with PTSD
NCT05837845Phase 2Recruiting
- Start
- Feb 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD). Started Feb 2025; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05837845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837845.